Stockscreener 앱 받기
4.54
2.48%
0.11
시간 외 거래:
4.58
0.04
+0.88%
전일 마감가:
$4.43
열려 있는:
$4.45
하루 거래량:
77,619
Relative Volume:
0.45
시가총액:
$278.82M
수익:
$45.15M
순이익/손실:
$-39.23M
주가수익비율:
-2.4822
EPS:
-1.829
순현금흐름:
$-18.93M
1주 성능:
+2.02%
1개월 성능:
+7.58%
6개월 성능:
+4.61%
1년 성능:
-9.56%
1일 변동 폭
$4.45
$4.71
1주일 범위
$4.3085
$4.71
52주 변동 폭
$3.42
$7.95
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.54 | 272.07M | 45.15M | -39.23M | -18.93M | -1.829 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
CSU environmental economist elected to National Academy of Sciences - BizWest
TradingKey - TradingKey
TriSalus (TLSI) Initiates Patient Enrollment for PREDICTT Liver Tumor Clinical Trial - Yahoo Finance UK
TriSalus Life Sciences Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance - Quantisnow
TriSalus Life Sciences Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
What you need to know before buying TriSalus (TLSI) (Buying Pressure) 2026-05-05Community Driven Stock Picks - newser.com
TriSalus initiates PREDICTT trial for liver tumor treatment By Investing.com - Investing.com South Africa
TLSIW Price History for Trisalus Life Sciences WT Stock - Barchart.com
TriSalus initiates PREDICTT trial for liver tumor treatment - Investing.com
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors - Weekly Voice
Can pressure improve liver tumor treatment? TriSalus opens study at MD Anderson - Stock Titan
The stress test results at TriSalus (TLSIW) | TLSIW Latest Quarter Earnings: TriSalus has no EPS or revenue data this quarterSocial Investment Platform - newser.com
Tangible book value per share of TriSalus Life Sciences, Inc. – NASDAQ:TLSIW - TradingView
Tristar Acquisition I Corp (TRIS) - Minichart
TLSI Stock Price, Quote & Chart | TRISALUS LIFE SCIENCES INC (NASDAQ:TLSI) - ChartMill
TriSalus Life Sciences Announces Planned Clinical Leadership Transition - TipRanks
TriSalus Life Sciences (NASDAQ: TLSI) outlines key leadership transitions - Stock Titan
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI) - The Globe and Mail
Quarterly results arrive before TriSalus' May 12 webcast - Stock Titan
JonesTrading Maintains TriSalus Life Sciences(TLSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Thought-leader group to discuss work-life balance - BizWest
TriSalus (TLSI) Stock: Buy Decision Analysis (Breakdown Watch) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Frankenius Equity swaps preferred for 759,000 TriSalus (TLSI) common shares - Stock Titan
TriSalus Life Sciences (NASDAQ:TLSI) Trading Up 2%Time to Buy? - MarketBeat
Bull Run: Will TriSalus Life Sciences Inc benefit from rate cuts2026 Retail & Weekly Hot Stock Watchlists - baoquankhu1.vn
Sentiment Recap: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2026 Earnings Impact & Consistent Profit Alerts - baoquankhu1.vn
TLSI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volume Summary: Is TriSalus Life Sciences Inc Equity Warrants growth already priced in2026 Price Swings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Aug Swings: Is TriSalus Life Sciences Inc stock a value trap2026 Risk Factors & Reliable Price Breakout Signals - baoquankhu1.vn
TriSalus Life Sciences to Present New Data at 2026 Radiology Conference - National Today
TriSalus to present drug delivery data at radiology meeting By Investing.com - Investing.com South Africa
TriSalus to present drug delivery data at radiology meeting - Investing.com
TriSalus brings liver and uterine treatment data to SIR 2026 - Stock Titan
TriSalus to elevate director to chief medical officer role - BizWest
Trisalus Life Sciences, Inc. Appoints Richard Marshall, M.D., as Chief Medical Officer, Effective June 29, 2026 - marketscreener.com
TriSalus names Richard Marshall as chief medical officer By Investing.com - Investing.com India
TriSalus Life Sciences, Inc. Files Form 8-K on April 1, 2026 Announcing Press Release and Company Information - Minichart
TriSalus names Richard Marshall as chief medical officer - Investing.com
TriSalus Life Sciences Names Richard Marshall Chief Medical Officer - TipRanks
Transcend Appoints Elizabeth Jackson as Senior Vice President of Marketing - Weekly Voice
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer - Weekly Voice
Oncology company TriSalus taps interventional radiologist as medical chief - Stock Titan
TriSalus Life Sciences (TLSI) taps Richard Marshall, M.D., as Chief Medical Officer - Stock Titan
Will TriSalus (TLSI) Stock Rise in 2026 | Price at $4.11, Down 3.07%Crowd Sentiment Stocks - newser.com
TLSI Technical Analysis & Stock Price Forecast - Intellectia AI
Laramie’s Unlocked Labs fights kidney stones with enzymes - BizWest
How does currency impact TriSalus (TLSI) Stock | Price at $4.24, Up 1.44%Wall Street Picks - newser.com
Director converts 100,000 TriSalus (TLSI) preferred shares into common - Stock Titan
TLSI Should I Buy - Intellectia AI
Revenue Check: Why is TriSalus Life Sciences Inc stock going up2026 Key Highlights & Entry Point Confirmation Signals - baoquankhu1.vn
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):